GDRX logo

GoodRx Holdings, Inc. (GDRX) Cash from operations

annual CFO:

$183.89M+$45.60M(+32.97%)
December 31, 2024

Summary

  • As of today (August 16, 2025), GDRX annual cash flow from operations is $183.89 million, with the most recent change of +$45.60 million (+32.97%) on December 31, 2024.
  • During the last 3 years, GDRX annual CFO has risen by +$5.11 million (+2.86%).
  • GDRX annual CFO is now at all-time high.

Performance

GDRX Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXcash flow metrics

quarterly CFO:

$49.58M+$40.17M(+426.72%)
June 30, 2025

Summary

  • As of today (August 16, 2025), GDRX quarterly cash flow from operations is $49.58 million, with the most recent change of +$40.17 million (+426.72%) on June 30, 2025.
  • Over the past year, GDRX quarterly CFO has increased by +$39.88 million (+411.08%).
  • GDRX quarterly CFO is now -42.92% below its all-time high of $86.86 million, reached on September 30, 2024.

Performance

GDRX quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXcash flow metrics

TTM CFO:

$190.60M+$39.88M(+26.46%)
June 30, 2025

Summary

  • As of today (August 16, 2025), GDRX TTM cash flow from operations is $190.60 million, with the most recent change of +$39.88 million (+26.46%) on June 30, 2025.
  • Over the past year, GDRX TTM CFO has increased by +$62.17 million (+48.41%).
  • GDRX TTM CFO is now at all-time high.

Performance

GDRX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

GDRX Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+33.0%+411.1%+48.4%
3 y3 years+2.9%-2.9%+6.2%
5 y5 years+120.8%+29.7%+127.4%

GDRX Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+33.0%-42.9%+426.7%at high+49.2%
5 y5-yearat high+120.8%-42.9%+426.7%at high+127.4%
alltimeall timeat high+306.4%-42.9%+426.7%at high+318.1%

GDRX Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$49.58M(+426.7%)
$190.60M(+26.5%)
Mar 2025
-
$9.41M(-79.0%)
$150.72M(-18.0%)
Dec 2024
$183.89M(+33.0%)
$44.74M(-48.5%)
$183.89M(+18.6%)
Sep 2024
-
$86.86M(+795.4%)
$155.02M(+20.7%)
Jun 2024
-
$9.70M(-77.2%)
$128.43M(-13.6%)
Mar 2024
-
$42.59M(+168.4%)
$148.59M(+7.4%)
Dec 2023
$138.29M(-5.8%)
$15.87M(-73.7%)
$138.29M(-10.4%)
Sep 2023
-
$60.27M(+101.8%)
$154.30M(+20.8%)
Jun 2023
-
$29.87M(-7.5%)
$127.77M(-14.2%)
Mar 2023
-
$32.29M(+1.3%)
$148.95M(+1.5%)
Dec 2022
$146.78M
$31.88M(-5.5%)
$146.78M(-10.9%)
Sep 2022
-
$33.73M(-33.9%)
$164.71M(-8.3%)
DateAnnualQuarterlyTTM
Jun 2022
-
$51.05M(+69.5%)
$179.54M(+9.9%)
Mar 2022
-
$30.12M(-39.5%)
$163.41M(-8.6%)
Dec 2021
$178.78M(+36.1%)
$49.81M(+2.6%)
$178.78M(+24.3%)
Sep 2021
-
$48.56M(+39.0%)
$143.82M(+12.4%)
Jun 2021
-
$34.93M(-23.2%)
$127.93M(-2.5%)
Mar 2021
-
$45.48M(+206.3%)
$131.23M(-0.1%)
Dec 2020
$131.34M(+57.7%)
$14.85M(-54.5%)
$131.34M(+12.7%)
Sep 2020
-
$32.67M(-14.6%)
$116.49M(+39.0%)
Jun 2020
-
$38.23M(-16.1%)
$83.83M(+83.9%)
Mar 2020
-
$45.59M
$45.59M
Dec 2019
$83.29M(+84.0%)
-
-
Dec 2018
$45.25M
-
-

FAQ

  • What is GoodRx Holdings, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. annual CFO year-on-year change?
  • What is GoodRx Holdings, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. quarterly CFO year-on-year change?
  • What is GoodRx Holdings, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for GoodRx Holdings, Inc.?
  • What is GoodRx Holdings, Inc. TTM CFO year-on-year change?

What is GoodRx Holdings, Inc. annual cash flow from operations?

The current annual CFO of GDRX is $183.89M

What is the all time high annual CFO for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high annual cash flow from operations is $183.89M

What is GoodRx Holdings, Inc. annual CFO year-on-year change?

Over the past year, GDRX annual cash flow from operations has changed by +$45.60M (+32.97%)

What is GoodRx Holdings, Inc. quarterly cash flow from operations?

The current quarterly CFO of GDRX is $49.58M

What is the all time high quarterly CFO for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high quarterly cash flow from operations is $86.86M

What is GoodRx Holdings, Inc. quarterly CFO year-on-year change?

Over the past year, GDRX quarterly cash flow from operations has changed by +$39.88M (+411.08%)

What is GoodRx Holdings, Inc. TTM cash flow from operations?

The current TTM CFO of GDRX is $190.60M

What is the all time high TTM CFO for GoodRx Holdings, Inc.?

GoodRx Holdings, Inc. all-time high TTM cash flow from operations is $190.60M

What is GoodRx Holdings, Inc. TTM CFO year-on-year change?

Over the past year, GDRX TTM cash flow from operations has changed by +$62.17M (+48.41%)
On this page